Literature DB >> 736604

[HLA antigen frequencies in patients with progressive systemic sclerosis and morphea (author's transl)].

J Freudenberg, H Holzmann, S Schneider, G W Korting.   

Abstract

Forty three patients with progressive systemic sclerosis and 24 patients with morphea are typed for 30 antigens of the HLA-A and B series. There is an increase of the frequency of HLA-B8 in patients with progressive systemic sclerosis (37% vs. 20% in controls: P less than 0.001, Pcorr. = n.s.). The increase of the HLA-B8 frequency seems to be most pronounced in patients with a diffuse form of progressive systemic sclerosis. 4 out of 5 patients are HLA-B8 positive (P = 0.00672). In patients with acrosclerosis is HLA-B8 only slightly increased (32%), but the increase is greater in male patients (44%) and in patients with an early onset of the disease (36%). With the exception of HLA-A1 there is no deviation of the frequencies of any other HLA antigen tested, especially not of HLA-Aw24. The number of patients with morphea is to small for statistical evaluation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 736604     DOI: 10.1007/bf00446441

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  11 in total

1.  [HLA antigens and susceptibility to disease].

Authors:  J Bertrams
Journal:  Dtsch Med Wochenschr       Date:  1976-01-30       Impact factor: 0.628

2.  [Research of an association between HL-A antigens and systemic scleroderma].

Authors:  J Crouzet; M C Marbach; J P Camus; P Godeau; G Herreman; D Richier; J Hors; J Dausset
Journal:  Nouv Presse Med       Date:  1975-10-18

3.  Evidence for genetic control of anti-insulin immunity in juvenile onset diabetes mellitus.

Authors:  G Schernthaner; H Ludwig; W R Mayr; H Frisch
Journal:  Diabete Metab       Date:  1977-06

4.  [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].

Authors:  H Ludwig; G Schernthaner; W R Mayr
Journal:  Dtsch Med Wochenschr       Date:  1977-08-26       Impact factor: 0.628

5.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

6.  [Simultaneous appearance of symptoms of circumscribed and progressive scleroderma].

Authors:  F Weidner; O Braun-Falco
Journal:  Hautarzt       Date:  1968-08       Impact factor: 0.751

7.  HLA in different forms of chronic active hepatitis. A comparison between adult patients and children.

Authors:  J Freudenberg; H Baumann; W Arnold; J Berger; K H Büschenfelde
Journal:  Digestion       Date:  1977       Impact factor: 3.216

8.  Letter: HL-A antigens in progressive systemic sclerosis (scleroderma).

Authors:  B S Rabin; G P Rodnan; S Bassion; T J Gill
Journal:  Arthritis Rheum       Date:  1975 Jul-Aug

9.  HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus.

Authors:  J Bertrams; F K Jansen; D Grüneklee; H E Reis; H Drost; J Beyer; F A Gries; E Kuwert
Journal:  Tissue Antigens       Date:  1976-07

10.  [Distribution of the HL-A antigens in patients with pigeon breeder's lung].

Authors:  J Sennekamp; C Rittner; F Vogel; I Täuberecht
Journal:  Schweiz Med Wochenschr       Date:  1978-02-25
View more
  6 in total

1.  HLA antigen frequencies in patients with Huntington's chorea and their relatives.

Authors:  K Foerster; J Freudenberg
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

2.  HLA-SD antigens in progressive systemic sclerosis.

Authors:  M Giordano; D Magrí; G Valentini; G Tirri; R De Biasi
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

3.  Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).

Authors:  C J Lynch; G Singh; T L Whiteside; G P Rodnan; T A Medsger; B S Rabin
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

4.  Diffuse systemic sclerosis and related diseases in Thailand.

Authors:  S Panicheewa; S Chitrabamrung; O Verasertniyom; M Vanichaphantu; S O Kraisit; P Chiewsilp; M Vatanasuk
Journal:  Clin Rheumatol       Date:  1991-06       Impact factor: 2.980

5.  Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.

Authors:  Heidi Jacobe; Chul Ahn; Frank C Arnett; John D Reveille
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

6.  Retroperitoneal fibrosis and scleroderma.

Authors:  M A Mansell; R W Watts
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.